Evidence map›Paper›PMID 30021876›Full record

ArticlemSphere2018

Rifampin- or Capreomycin-Induced Remodeling of the

DeDe Kwun-Wai Man, Tokuwa Kanno, Giorgia Manzo, Brian D Robertson, Jenny K W Lam, A James Mason

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. MadR mediates acyl CoA-dependent regulation of mycolic acid desaturation in mycobacteria.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

DeDe Kwun-Wai ManInstitute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Tokuwa KannoInstitute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Giorgia ManzoInstitute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Brian D RobertsonMRC Centre for Molecular Bacteriology and Infection, Department of Medicine, Imperial College London, London, United Kingdom.
Jenny K W LamDepartment of Pharmacology & Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.
A James MasonInstitute of Pharmaceutical Sciences, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom james.mason@kcl.ac.uk.ORCID 0000-0003-0411-602X
King's College London · GBImperial College London · GBUniversity of Hong Kong · HK

Funding

Cancer Research UK FC001029Medical Research Council FC001029Medical Research Council MC_U117533887Medical Research Council MR/P028225/1Wellcome Trust FC001029
6 · The paper itself

Abstract

The mycobacterial cell wall affords natural resistance to antibiotics. Antimicrobial peptides (AMPs) modify the surface properties of mycobacteria and can act synergistically with antibiotics from differing classes. Here, we investigate the response of

Indexed as

Drug SynergismAnti-Infective AgentsAntimicrobial Cationic PeptidesCapreomycinCell WallFluorescence PolarizationMagnetic Resonance SpectroscopyMetabolomicsMycobacterium smegmatisMycolic AcidsPhotoelectron SpectroscopyRifampinAnti-Infective AgentsAntimicrobial Cationic PeptidesCapreomycinMycolic AcidsRifampincapreomycinmycobacteriaNMR metabolomicsrifampinsynergytyloxapol

Identifiers

PMID30021876
PMCPMC6052339
OpenAlexW2794918485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.